LOGSX vs. PRHSX

Last updated Jun 4, 2026

LOGSX (Live Oak Health Sciences Fund) and PRHSX (T. Rowe Price Health Sciences Fund) are both Health & Biotech Equities funds. Over the past 10 years, LOGSX returned 6.37%/yr vs 9.98%/yr for PRHSX. Their correlation of 0.84 suggests significant overlap in exposure. LOGSX charges 1.02%/yr vs 0.80%/yr for PRHSX.

Performance

LOGSX vs. PRHSX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Live Oak Health Sciences Fund (LOGSX) and T. Rowe Price Health Sciences Fund (PRHSX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LOGSX achieves a -3.06% return, which is significantly higher than PRHSX's -5.20% return. Over the past 10 years, LOGSX has underperformed PRHSX with an annualized return of 6.37%, while PRHSX has yielded a comparatively higher 9.98% annualized return.

LOGSX

• 1D: -1.13%
• 1M: -1.34%
• YTD: -3.06%
• 6M: -2.57%
• 1Y: 13.04%
• 3Y*: 7.87%
• 5Y*: 5.71%
• 10Y*: 6.37%

PRHSX

• 1D: -2.17%
• 1M: -0.75%
• YTD: -5.20%
• 6M: -5.57%
• 1Y: 17.50%
• 3Y*: 5.15%
• 5Y*: 2.69%
• 10Y*: 9.98%

*Multi-year figures are annualized to reflect compound growth (CAGR)

LOGSX vs. PRHSX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
LOGSX Live Oak Health Sciences Fund	-3.06%	19.63%	0.16%	1.21%	3.71%	17.59%	6.01%	18.98%	-3.84%	13.42%
PRHSX T. Rowe Price Health Sciences Fund	-5.20%	17.75%	1.82%	3.03%	-12.22%	13.50%	30.19%	37.88%	1.08%	28.04%

Correlation

The correlation between LOGSX and PRHSX is 0.79, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.79
Correlation (3Y) Calculated over the trailing 3-year period	0.77
Correlation (5Y) Calculated over the trailing 5-year period	0.81
Correlation (10Y) Calculated over the trailing 10-year period	0.81
Correlation (All Time) Calculated using the full available price history since Jul 2, 2001	0.84

The correlation between LOGSX and PRHSX has been stable across timeframes, ranging from 0.77 to 0.84 - a consistent structural relationship.

Return for Risk

LOGSX vs. PRHSX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LOGSX

LOGSX Risk / Return Rank: 14
LOGSX Sharpe Ratio Rank: 12
LOGSX Sortino Ratio Rank: 13
LOGSX Omega Ratio Rank: 12
LOGSX Calmar Ratio Rank: 20
LOGSX Martin Ratio Rank: 15

PRHSX

PRHSX Risk / Return Rank: 16
PRHSX Sharpe Ratio Rank: 17
PRHSX Sortino Ratio Rank: 18
PRHSX Omega Ratio Rank: 16
PRHSX Calmar Ratio Rank: 16
PRHSX Martin Ratio Rank: 14

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LOGSX vs. PRHSX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Live Oak Health Sciences Fund (LOGSX) and T. Rowe Price Health Sciences Fund (PRHSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	LOGSX	PRHSX	Difference
Sharpe ratio: Return per unit of total volatility	0.96	1.17	-0.22
Sortino ratio: Return per unit of downside risk	1.44	1.77	-0.33
Omega ratio: Gain probability vs. loss probability	1.17	1.20	-0.03
Calmar ratio: Return relative to maximum drawdown	1.65	1.41	+0.24
Martin ratio: Return relative to average drawdown	4.23	4.07	+0.16
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

LOGSX vs. PRHSX - Sharpe Ratio Comparison

The current LOGSX Sharpe Ratio is 0.96, which is comparable to the PRHSX Sharpe Ratio of 1.17. The chart below compares the historical Sharpe Ratios of LOGSX and PRHSX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	LOGSX	PRHSX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.96	1.17	-0.22
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.40	0.16	+0.25
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.40	0.52	-0.12
Sharpe Ratio (All Time) Calculated using the full available price history	0.42	0.61	-0.19

Drawdowns

LOGSX vs. PRHSX - Drawdown Comparison

The maximum LOGSX drawdown since its inception was -45.85%, which is greater than PRHSX's maximum drawdown of -42.96%. Use the drawdown chart below to compare losses from any high point for LOGSX and PRHSX.

Drawdown Indicators

	LOGSX	PRHSX	Difference
Max Drawdown Largest peak-to-trough decline	-45.85%	-42.96%	-2.89%
Max Drawdown (1Y) Largest decline over 1 year	-8.13%	-12.81%	+4.68%
Max Drawdown (3Y) Largest decline over 3 years	-14.33%	-21.00%	+6.67%
Max Drawdown (5Y) Largest decline over 5 years	-15.03%	-27.61%	+12.58%
Max Drawdown (10Y) Largest decline over 10 years	-27.28%	-28.97%	+1.69%
Current Drawdown Current decline from peak	-8.13%	-8.17%	+0.04%
Average Drawdown Average peak-to-trough decline	-7.61%	-8.75%	+1.14%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.17%	4.44%	-1.27%

Volatility

LOGSX vs. PRHSX - Volatility Comparison

The current volatility for Live Oak Health Sciences Fund (LOGSX) is 3.70%, while T. Rowe Price Health Sciences Fund (PRHSX) has a volatility of 4.89%. This indicates that LOGSX experiences smaller price fluctuations and is considered to be less risky than PRHSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LOGSX	PRHSX	Difference
Volatility (1M) Calculated over the trailing 1-month period	3.70%	4.89%	-1.19%
Volatility (6M) Calculated over the trailing 6-month period	10.07%	11.96%	-1.89%
Volatility (1Y) Calculated over the trailing 1-year period	14.04%	15.45%	-1.41%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	14.19%	17.25%	-3.06%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	16.13%	19.26%	-3.13%

LOGSX vs. PRHSX - Expense Ratio Comparison

LOGSX has a 1.02% expense ratio, which is higher than PRHSX's 0.80% expense ratio.

Dividends

LOGSX vs. PRHSX - Dividend Comparison

LOGSX's dividend yield for the trailing twelve months is around 2.14%, less than PRHSX's 12.76% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
LOGSX Live Oak Health Sciences Fund	2.14%	2.07%	2.64%	6.28%	0.55%	7.02%	7.04%	0.85%	15.20%	6.45%	2.10%	15.52%
PRHSX T. Rowe Price Health Sciences Fund	12.76%	12.09%	12.89%	5.21%	1.77%	7.46%	7.16%	12.29%	6.57%	7.43%	4.55%	11.34%

Frequently Asked Questions

Can I hold both LOGSX and PRHSX in my portfolio?

LOGSX and PRHSX have a correlation of 0.79, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LOGSX or PRHSX?

PRHSX has higher volatility (4.89%) compared to LOGSX (3.70%). In terms of maximum drawdown, LOGSX dropped -45.85% vs PRHSX's -42.96%.

Which has better risk-adjusted returns?

PRHSX currently has the higher Sharpe Ratio (1.17 vs 0.96), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.